Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edward Chang

Plastic and Reconstructive Surgery Houston, TX Medical Doctor

NPI 1053486977 CMS profile 274426

1515 Holcombe Blvd, Houston, TX 77030

Open in the dashboard

General payments

$110,654

235 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$220 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Edward Chang of Houston, TX is reported in the CMS Open Payments database as having received $110,654 across 235 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $220 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,657 26
2024 General $42,735 50
2023 General $13,154 38
2022 General $3,136 28
2021 General $6,645 52
2020 General $13,277 15
2019 General $2,049 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edward Chang
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Edward Chang were reported at $29,657. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Edward Chang Plastic and Reconstructive Surgery median Middle half National median
2019 $2,049 $335 $121–$1,264 $163
2020 $13,277 $162 $57–$417 $114
2021 $6,645 $245 $89–$735 $132
2022 $3,136 $325 $120–$932 $149
2023 $13,154 $343 $129–$999 $160
2024 $42,735 $390 $141–$1,085 $164
2025 $29,657 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Musculoskeletal Transplant Foundation Inc. $76,325 50 payments
  2. KLS-Martin L.P. $9,559 8 payments
  3. Baxter Healthcare $4,074 29 payments
  4. Integra LifeSciences Corporation $3,374 41 payments
  5. Allergan Inc. $2,110 11 payments
  6. DePuy Synthes Sales Inc. $1,811 29 payments
  7. AbbVie, Inc. $1,692 8 payments
  8. Stryker Corporation $1,623 12 payments
  9. Motiva USA, LLC $1,523 7 payments
  10. Bimini Technologies LLC $1,500 1 payment
  11. Other $7,063 39 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $73,234 21 payments
  2. Food and Beverage $14,094 176 payments
  3. Travel and Lodging $11,739 32 payments
  4. Honoraria $11,500 5 payments
  5. Gift $87 1 payment
Products named General payments · program years 2019–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS $4,010 18 payments
  2. No Related Product $2,869 16 payments
  3. SURGIMEND $2,520 32 payments
  4. REVOLVE $1,948 8 payments
  5. Motiva Implant Matrix $1,354 6 payments
  6. Integra Recon-Skin And Wound $1,255 12 payments
  7. Integra Recon-Skin And Wound $1,255 12 payments
  8. INTEGRA DERMAL REGENERATION TEMPLATE $1,255 12 payments
  9. V.A.C. VERAFLO $1,200 1 payment
  10. ABTHERA $1,200 1 payment
  11. Other $17,788 121 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 72 billing codes

Paid by Medicare

$86,068

Medicare's payments for the services billed

Medicare patients

57

Average age 72

Services billed

197

31 women, 26 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 44%
Cancer 35%
Ischemic heart disease 32%
Diabetes 25%
Depression 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $24
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

235 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record